Where's the HIV Glossary?

The HIV Glossary formerly hosted on our site has been removed.

 

If you think you may have been infected with HIV/AIDS, please find a place to get a free, confidential HIV test.

 


HIV counselor in front of magnet board

HIV Info

Of the more than one million people estimated to be living with HIV in the United States, one in five don't know they're infected. The best way to fight HIV is to know your status.


If you think you may have been infected with HIV/AIDS, we encourage you to get a free, confidential HIV test.

Have questions about HIV/AIDS? We have answers to Frequently Asked Questions.

HIV stands for the Human Immunodeficiency Virus, and is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).  It is a virus that attacks the immune system. 

Over time, and without treatment, HIV gradually destroys the body's defenses against disease, leaving it vulnerable to many infections and cancers that do not normally develop.

AIDS is a late stage of HIV disease.  By the time of an AIDS diagnosis, HIV has already seriously damaged the body's immune system.  Often, a person living with AIDS will already have had life-threatening infections or cancers. 

Learn more about acquiring HIV, testing for HIV, and HIV treatment options.

Switch on your HIV Smarts with BETA

The Bulletin of Experimental Treatments for AIDS is your bright and brainy source on new developments in HIV prevention, evolving approaches to HIV treatment, and strategies for living well with the virus.

Latest BETA News

“On-Demand” PrEP Shows High Efficacy in IPERGAY Trial

“On-Demand” PrEP Shows High Efficacy in IPERGAY Trial

BETA is attending and reporting from the 2015 Conference on Retroviruses and Opportunistic Infections this week in Seattle from February 23 to 26—bringing you the latest news, updates, and research … Read More

Partners PrEP Demo project: Near Elimination of HIV Transmission with ART and PrEP

Partners PrEP Demo project: Near Elimination of HIV Transmission with ART and PrEP

BETA is attending and reporting from the 2015 Conference on Retroviruses and Opportunistic Infections this week in Seattle from February 23 to 26—bringing you the latest news, updates, and research … Read More

PROUD Study of “Real World” PrEP Reports 86% Efficacy

PROUD Study of “Real World” PrEP Reports 86% Efficacy

BETA is attending and reporting from the 2015 Conference on Retroviruses and Opportunistic Infections this week in Seattle from February 23 to 26—bringing you the latest news, updates, and research … Read More

CROI 2015: Neutralizing Antibodies Provide Hope for an HIV Vaccine

CROI 2015: Neutralizing Antibodies Provide Hope for an HIV Vaccine

BETA is attending and reporting from the 2015 Conference on Retroviruses and Opportunistic Infections this week in Seattle from February 23 to 26—bringing you the latest news, updates, and research … Read More

PrEP-ing for Prevention at CROI 2015

PrEP-ing for Prevention at CROI 2015

BETA is attending and reporting from the 2015 Conference on Retroviruses and Opportunistic Infections this week in Seattle from February 23 to 26—bringing you the latest news, updates, and research … Read More

PrEP in the Spotlight: Sound Bites from Creating Change

PrEP in the Spotlight: Sound Bites from Creating Change

As more and more people start to talk about pre-exposure prophylaxis (PrEP), how can we make sure that people are hearing accurate information about this effective way to prevent HIV? … Read More

Semen Found to Impair Microbicide Efficacy

Semen Found to Impair Microbicide Efficacy

Microbicides are a form of drug—usually in a gel or cream—that can be applied in the vagina or rectum to prevent HIV before exposure. Their development and use has been … Read More

See more articles on the BETA Blog...